MARATTO

article · Research Journal of Applied Biotechnology

Synthesis, characterization and biological activity of cadmium (II) complex of hydrazone moiety

20241 citationOpen accessUniversity of Sadat City

Abstract

With the aid of hydrazone moiety, a novel Cd(II) chelate with 2-[(4-methylphenyl)amino]-N'-[(Z)-thiophen-2-ylmethylidene]acetohydrazide (H2L) was created and reported. These novel chemicals' structural makeup was clarified through the utilization of spectroscopic and analytical methods. The chelates were molded with a molar ratio of 1:1 M:L and the formula [Cd(H2L)Cl2]. Cd(II) complex of the biological activity ligand is investigated. Theoretical measurements supported the proposed generic formula for the [Cd(H2L)Cl2] complex. The compound's anticancer and antibacterial properties were evaluated using cisplatin, gentamicin, and ampicillin as standards. It was found that the Cd 2+ complex was more effective against two cancer cell lines and several bacterial strains than it was against ligand. The results showed that the compound's activities were: Cd(II) complex > H2L, with Cd(II) complex exhibiting the maximum activity. By examining the binding between the complex and Penicillin-binding protein PBP, which is primarily thought of as the production of the cell wall through its transglycosylation and transpeptidation, a molecular docking study was carried out to support the microbial inhibition growth.

Research topics

  • Inorganic and Organometallic Chemistry

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/rjab.2024.312873.1055

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.